0
0
Canada has also granted emergency approval for the coronavirus vaccine from the Mainz-based company Biontech and its U.S. partner Pfizer. This was announced today by the Canadian health authorities and both companies. This means that the Canadians will receive the green light earlier than the EU and the USA, where corresponding applications are currently still being examined. The vaccine has been in use in the UK since Tuesday and has also been approved in the Arab Gulf State of Bahrain.
The application for emergency marketing authorization was received on October 9 and has since been “thoroughly and independently” reviewed by the Canadian health authority, it said. As a result, it was found that the vaccine meets the necessary safety and quality requirements. “Canadians can feel confident that the review process was rigorous and that we have a strong surveillance system in place.
Numbers have risen sharply
In the North American country with a population of around 38 million, around 430,000 people have been infected with the coronavirus to date and around 13,000 have died after infection. Recently, the numbers have risen sharply. By the end of 2021, Canada should receive at least 20 and at most 76 million doses of vaccine, Pfizer and Biontech announced.
According to the companies, extensive test series for the Biontech and Pfizer vaccine have shown a 95 percent efficacy against the disease Covid-19. The responsible authorities in the EU and the USA want to decide on applications for emergency approval in December.
hp, Source. ORF.at/agencies. picture: pixabay.com
This post has already been read 783 times!
